Cancer and the circadian clock: has the time finally come?
Hede
Karyn
K
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001683:Biological Clocks / Q000235:genetics*; D015415:Biomarkers / Q000032:analysis; D018797:Cell Cycle Proteins / Q000032:analysis; D002940:Circadian Rhythm / Q000235:genetics*; D056931:Cryptochromes; D004260:DNA Repair / Q000528:radiation effects; D004334:Drug Administration Schedule; D005260:Female; D005420:Flavoproteins / Q000032:analysis; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D009687:Nuclear Proteins / Q000032:analysis; D010051:Ovarian Neoplasms / Q000188:drug therapy; D056950:Period Circadian Proteins; D011237:Predictive Value of Tests; D011379:Prognosis; D013997:Time Factors; D014157:Transcription Factors / Q000032:analysis; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D014466:Ultraviolet Rays / Q000009:adverse effects
D015415:Biomarkers; D018797:Cell Cycle Proteins; D056931:Cryptochromes; D005420:Flavoproteins; D009687:Nuclear Proteins; C421902:PER2 protein, human; C513312:Per2 protein, mouse; D056950:Period Circadian Proteins; D014157:Transcription Factors; D016159:Tumor Suppressor Protein p53